Alnylam Pharmaceuticals
ALNY
#622
Rank
โ‚น2.699 T
Marketcap
โ‚น20,931
Share price
2.75%
Change (1 day)
39.00%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Alnylam Pharmaceuticals (ALNY) - Net assets

Net assets on the balance sheet as of September 2024 : โ‚น2.75 Billion

According to Alnylam Pharmaceuticals 's latest financial reports the company has โ‚น2.75 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Alnylam Pharmaceuticals - Net assets on balance sheet (from 2003 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$-โ‚น18.37 Billion40.29%
2022-12-31$-โ‚น13.1 Billion-129.91%
2021-12-31$โ‚น43.78 B-41.09%
2020-12-31$โ‚น74.32 B-27.56%
2019-12-31$โ‚น102.59 B12.7%
2018-12-31$โ‚น91.03 B-19.29%
2017-12-31$โ‚น112.78 B80.36%
2016-12-31$โ‚น62.53 B-25.6%
2015-12-31$โ‚น84.04 B41.64%
2014-12-31$โ‚น59.33 B255.28%
2013-12-31$โ‚น16.70 B127.55%
2012-12-31$โ‚น7.33 B17.59%
2011-12-31$โ‚น6.24 B-11.97%
2010-12-31$โ‚น7.09 B-14.13%
2009-12-31$โ‚น8.25 B-15%
2008-12-31$โ‚น9.71 B24.29%
2007-12-31$โ‚น7.81 B-12.27%
2006-12-31$โ‚น8.90 B220.5%
2005-12-31$โ‚น2.78 B39.12%
2004-12-31$โ‚น1.99 B-264.34%
2003-12-31$-โ‚น1.22 Billion445.78%
2002-12-31$-โ‚น0.23 Billion

Net assets for similar companies or competitors

Company Net assets differencediff. Country
โ‚น16.29 B 490.54%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น2.500 T 90,540.72%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น104.13 B 3,674.09%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น119.68 B 4,237.70%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น7.40 B 168.30%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น3.704 T 134,167.79%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚น6.673 T 241,760.67%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚น544.42 B 19,631.72%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel